                               SEQUENCE LISTING                               

<110> TOVI, AVI
      EIDELMAN, CHAIM
      SHUSHAN, SHIMON
      ELSTER, SHAI
      HAGI, ALON
      IVCHENKO, ALEXANDER
      BUTILCA, GABRIEL-MARCUS
      ZAOUI, GIL
      ALTERMAN, ELEONORA
      BAR-OZ, LEAH

<120> HIGH PURITY PEPTIDES

<130> 12647/A400US1

<140>
<141>

<150> 60/904,512
<151> 2007-03-01

<150> 60/995,652
<151> 2007-09-26

<150> 60/997,285
<151> 2007-10-01

<160> 11                            

<170> PatentIn Ver. 3.3

<210> 1
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      nesiritide peptide

<400> 1
Ser Pro Lys Met Val Gln Gly Ser Gly Cys Phe Gly Arg Lys Met Asp  
  1               5                  10                  15    

Arg Ile Ser Ser Ser Ser Gly Leu Gly Cys Lys Val Leu Arg Arg His  
             20                  25                  30        

                                                                 



<210> 2
<211> 39
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      exenatide peptide

<400> 2
His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu  
  1               5                  10                  15    

Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asp Gly Gly Pro Ser  
             20                  25                  30        

Ser Gly Ala Pro Pro Pro Ser                                      
         35                


<210> 3
<211> 36
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      enfuvirtide peptide

<400> 3
Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Glu Ser Gln Asn Gln Gln  
  1               5                  10                  15    

Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu Asp Lys Trp Ala Ser Leu  
             20                  25                  30        

Trp Asn Trp Phe                                                  
         35    


<210> 4
<211> 34
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      teriparatide peptide

<400> 4
Ser Val Ser Glu Ile Gln Leu Met His Asn Leu Gly Lys His Leu Asn  
  1               5                  10                  15    

Ser Met Glu Arg Val Glu Trp Leu Arg Lys Lys Leu Gln Asp Val His  
             20                  25                  30        

Asn Phe                                                          
       


<210> 5
<211> 31
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<221> MOD_RES
<222> (6)
<223> Asu

<400> 5
Ser Asn Leu Ser Thr Xaa Val Leu Gly Lys Leu Ser Gln Glu Leu His  
  1               5                  10                  15    

Lys Leu Gln Thr Tyr Pro Arg Thr Asp Val Gly Ala Gly Thr Pro      
             20                  25                  30    


<210> 6
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      bivalirudin peptide

<400> 6
Phe Pro Arg Pro Gly Gly Gly Gly Asn Gly Asp Phe Glu Glu Ile Pro  
  1               5                  10                  15    

Glu Glu Tyr Leu                                                  
             20


<210> 7
<211> 33
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      sermorelin peptide

<400> 7
Tyr Ala Asp Ala Ile Tyr Ala Asp Ile Phe Thr Asn Ser Tyr Arg Lys  
  1               5                  10                  15    

Val Leu Gly Gln Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Met Ser  
             20                  25                  30        

Arg
                                                                 



<210> 8
<211> 41
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      corticorelin peptide

<400> 8
Ser Gln Glu Pro Pro Ile Ser Leu Asp Leu Thr Phe His Leu Leu Arg  
  1               5                  10                  15    

Glu Val Leu Glu Met Thr Lys Ala Asp Gln Leu Ala Gln Gln Ala His  
             20                  25                  30        

Ser Asn Arg Lys Leu Leu Asp Ile Ala                              
         35                  40    


<210> 9
<211> 28
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      thymosin alpha 1 peptide

<400> 9
Ser Asp Ala Ala Val Asp Thr Ser Ser Glu Ile Thr Thr Lys Asp Leu  
  1               5                  10                  15    

Lys Glu Lys Lys Glu Val Val Glu Glu Ala Glu Asn                  
             20                  25            


<210> 10
<211> 27
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      secretin peptide

<400> 10
His Ser Asp Gly Thr Phe Thr Ser Glu Leu Ser Arg Leu Arg Asp Ser  
  1               5                  10                  15    

Ala Arg Leu Gln Arg Leu Leu Gln Gly Leu Val                      
             20                  25        


<210> 11
<211> 37
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      pramlintide peptide

<400> 11
Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu  
  1               5                  10                  15    

Val His Ser Ser Asn Asn Phe Gly Pro Ile Leu Pro Pro Thr Asn Val  
             20                  25                  30        

Gly Ser Asn Thr Tyr                                              
         35        


